 | • レポートコード：QFJ1-5566 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、急性腎障害治療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非薬物式、薬物式）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・急性腎障害治療法の市場動向 ・企業の競争状況、市場シェア ・急性腎障害治療法の種類別市場規模と予測2016-2027（非薬物式、薬物式） ・急性腎障害治療法の用途別市場規模と予測2016-2027（病院、診療所、その他） ・急性腎障害治療法の北米市場規模2016-2027（アメリカ、カナダ） ・急性腎障害治療法の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・急性腎障害治療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・急性腎障害治療法の中南米市場規模2016-2027（メキシコ、ブラジル） ・急性腎障害治療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Quark Pharmaceuticals、Alloksys、Angio Biomedica Corporation、Stealth Bio Therapeutics、Silver Creek Pharmaceuticals、AM Pharma Holding、Ischemix、Biomerieux、A1M Pharma） ・結論 |
Acute kidney injury therapeutics is the cure to the acute kidney injury that is a group of clinical syndromes that refers to sudden (within 1-7d) and sustained (> 24h) sudden declines in renal function. It is defined as an increase in serum creatinine (SCr) of at least 0.5mg / dl 1 and manifested as nitrogen. Plasmaemia, water-electrolyte and acid-base balance and systemic symptoms can be accompanied by oliguria (<400ml / 24h or 17ml / h) or anuria (<100ml / 24h). Market Analysis and Insights: Global Acute Kidney Injury Therapeutics Market The global Acute Kidney Injury Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acute Kidney Injury Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acute Kidney Injury Therapeutics market in terms of revenue. On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acute Kidney Injury Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acute Kidney Injury Therapeutics market. Global Acute Kidney Injury Therapeutics Scope and Market Size Acute Kidney Injury Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acute Kidney Injury Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment by Type Non-drug Drugs Segment by Application Hospitals Clinic Other By Region North America United States Canada Europe Germany France U.K. Italy Russia Nordic Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA By Company Quark Pharmaceuticals Alloksys Angio Biomedica Corporation Stealth Bio Therapeutics Silver Creek Pharmaceuticals AM Pharma Holding Ischemix Biomerieux A1M Pharma
レポート目次1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Kidney Injury Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Non-drug
1.2.3 Drugs
1.3 Market by Application
1.3.1 Global Acute Kidney Injury Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Acute Kidney Injury Therapeutics Market Perspective (2016-2027)
2.2 Acute Kidney Injury Therapeutics Growth Trends by Regions
2.2.1 Acute Kidney Injury Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Acute Kidney Injury Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Acute Kidney Injury Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Acute Kidney Injury Therapeutics Industry Dynamic
2.3.1 Acute Kidney Injury Therapeutics Market Trends
2.3.2 Acute Kidney Injury Therapeutics Market Drivers
2.3.3 Acute Kidney Injury Therapeutics Market Challenges
2.3.4 Acute Kidney Injury Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acute Kidney Injury Therapeutics Players by Revenue
3.1.1 Global Top Acute Kidney Injury Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Acute Kidney Injury Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Acute Kidney Injury Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Acute Kidney Injury Therapeutics Revenue
3.4 Global Acute Kidney Injury Therapeutics Market Concentration Ratio
3.4.1 Global Acute Kidney Injury Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Kidney Injury Therapeutics Revenue in 2020
3.5 Acute Kidney Injury Therapeutics Key Players Head office and Area Served
3.6 Key Players Acute Kidney Injury Therapeutics Product Solution and Service
3.7 Date of Enter into Acute Kidney Injury Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acute Kidney Injury Therapeutics Breakdown Data by Type
4.1 Global Acute Kidney Injury Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Acute Kidney Injury Therapeutics Forecasted Market Size by Type (2022-2027)
5 Acute Kidney Injury Therapeutics Breakdown Data by Application
5.1 Global Acute Kidney Injury Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Acute Kidney Injury Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Acute Kidney Injury Therapeutics Market Size (2016-2027)
6.2 North America Acute Kidney Injury Therapeutics Market Size by Type
6.2.1 North America Acute Kidney Injury Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Acute Kidney Injury Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Acute Kidney Injury Therapeutics Market Size by Type (2016-2027)
6.3 North America Acute Kidney Injury Therapeutics Market Size by Application
6.3.1 North America Acute Kidney Injury Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Acute Kidney Injury Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Acute Kidney Injury Therapeutics Market Size by Application (2016-2027)
6.4 North America Acute Kidney Injury Therapeutics Market Size by Country
6.4.1 North America Acute Kidney Injury Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Acute Kidney Injury Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Acute Kidney Injury Therapeutics Market Size (2016-2027)
7.2 Europe Acute Kidney Injury Therapeutics Market Size by Type
7.2.1 Europe Acute Kidney Injury Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Acute Kidney Injury Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Acute Kidney Injury Therapeutics Market Size by Type (2016-2027)
7.3 Europe Acute Kidney Injury Therapeutics Market Size by Application
7.3.1 Europe Acute Kidney Injury Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Acute Kidney Injury Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Acute Kidney Injury Therapeutics Market Size by Application (2016-2027)
7.4 Europe Acute Kidney Injury Therapeutics Market Size by Country
7.4.1 Europe Acute Kidney Injury Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Acute Kidney Injury Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Acute Kidney Injury Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Type
8.2.1 Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Application
8.3.1 Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Region
8.4.1 Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Acute Kidney Injury Therapeutics Market Size (2016-2027)
9.2 Latin America Acute Kidney Injury Therapeutics Market Size by Type
9.2.1 Latin America Acute Kidney Injury Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Acute Kidney Injury Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Acute Kidney Injury Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Acute Kidney Injury Therapeutics Market Size by Application
9.3.1 Latin America Acute Kidney Injury Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Acute Kidney Injury Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Acute Kidney Injury Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Acute Kidney Injury Therapeutics Market Size by Country
9.4.1 Latin America Acute Kidney Injury Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Acute Kidney Injury Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acute Kidney Injury Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Type
10.2.1 Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Application
10.3.1 Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Country
10.4.1 Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Quark Pharmaceuticals
11.1.1 Quark Pharmaceuticals Company Details
11.1.2 Quark Pharmaceuticals Business Overview
11.1.3 Quark Pharmaceuticals Acute Kidney Injury Therapeutics Introduction
11.1.4 Quark Pharmaceuticals Revenue in Acute Kidney Injury Therapeutics Business (2016-2021)
11.1.5 Quark Pharmaceuticals Recent Development
11.2 Alloksys
11.2.1 Alloksys Company Details
11.2.2 Alloksys Business Overview
11.2.3 Alloksys Acute Kidney Injury Therapeutics Introduction
11.2.4 Alloksys Revenue in Acute Kidney Injury Therapeutics Business (2016-2021)
11.2.5 Alloksys Recent Development
11.3 Angio Biomedica Corporation
11.3.1 Angio Biomedica Corporation Company Details
11.3.2 Angio Biomedica Corporation Business Overview
11.3.3 Angio Biomedica Corporation Acute Kidney Injury Therapeutics Introduction
11.3.4 Angio Biomedica Corporation Revenue in Acute Kidney Injury Therapeutics Business (2016-2021)
11.3.5 Angio Biomedica Corporation Recent Development
11.4 Stealth Bio Therapeutics
11.4.1 Stealth Bio Therapeutics Company Details
11.4.2 Stealth Bio Therapeutics Business Overview
11.4.3 Stealth Bio Therapeutics Acute Kidney Injury Therapeutics Introduction
11.4.4 Stealth Bio Therapeutics Revenue in Acute Kidney Injury Therapeutics Business (2016-2021)
11.4.5 Stealth Bio Therapeutics Recent Development
11.5 Silver Creek Pharmaceuticals
11.5.1 Silver Creek Pharmaceuticals Company Details
11.5.2 Silver Creek Pharmaceuticals Business Overview
11.5.3 Silver Creek Pharmaceuticals Acute Kidney Injury Therapeutics Introduction
11.5.4 Silver Creek Pharmaceuticals Revenue in Acute Kidney Injury Therapeutics Business (2016-2021)
11.5.5 Silver Creek Pharmaceuticals Recent Development
11.6 AM Pharma Holding
11.6.1 AM Pharma Holding Company Details
11.6.2 AM Pharma Holding Business Overview
11.6.3 AM Pharma Holding Acute Kidney Injury Therapeutics Introduction
11.6.4 AM Pharma Holding Revenue in Acute Kidney Injury Therapeutics Business (2016-2021)
11.6.5 AM Pharma Holding Recent Development
11.7 Ischemix
11.7.1 Ischemix Company Details
11.7.2 Ischemix Business Overview
11.7.3 Ischemix Acute Kidney Injury Therapeutics Introduction
11.7.4 Ischemix Revenue in Acute Kidney Injury Therapeutics Business (2016-2021)
11.7.5 Ischemix Recent Development
11.8 Biomerieux
11.8.1 Biomerieux Company Details
11.8.2 Biomerieux Business Overview
11.8.3 Biomerieux Acute Kidney Injury Therapeutics Introduction
11.8.4 Biomerieux Revenue in Acute Kidney Injury Therapeutics Business (2016-2021)
11.8.5 Biomerieux Recent Development
11.9 A1M Pharma
11.9.1 A1M Pharma Company Details
11.9.2 A1M Pharma Business Overview
11.9.3 A1M Pharma Acute Kidney Injury Therapeutics Introduction
11.9.4 A1M Pharma Revenue in Acute Kidney Injury Therapeutics Business (2016-2021)
11.9.5 A1M Pharma Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Acute Kidney Injury Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Non-drug
Table 3. Key Players of Drugs
Table 4. Global Acute Kidney Injury Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Acute Kidney Injury Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Acute Kidney Injury Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Acute Kidney Injury Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Acute Kidney Injury Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Acute Kidney Injury Therapeutics Market Share by Regions (2022-2027)
Table 10. Acute Kidney Injury Therapeutics Market Trends
Table 11. Acute Kidney Injury Therapeutics Market Drivers
Table 12. Acute Kidney Injury Therapeutics Market Challenges
Table 13. Acute Kidney Injury Therapeutics Market Restraints
Table 14. Global Acute Kidney Injury Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Acute Kidney Injury Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Acute Kidney Injury Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Kidney Injury Therapeutics as of 2020)
Table 17. Ranking of Global Top Acute Kidney Injury Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Acute Kidney Injury Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Acute Kidney Injury Therapeutics Product Solution and Service
Table 21. Date of Enter into Acute Kidney Injury Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Acute Kidney Injury Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Acute Kidney Injury Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Acute Kidney Injury Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Acute Kidney Injury Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Acute Kidney Injury Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Acute Kidney Injury Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Acute Kidney Injury Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Acute Kidney Injury Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Acute Kidney Injury Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Acute Kidney Injury Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Acute Kidney Injury Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Acute Kidney Injury Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Acute Kidney Injury Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Acute Kidney Injury Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Acute Kidney Injury Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Acute Kidney Injury Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Acute Kidney Injury Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Acute Kidney Injury Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Acute Kidney Injury Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Acute Kidney Injury Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Acute Kidney Injury Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Acute Kidney Injury Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Acute Kidney Injury Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Acute Kidney Injury Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Acute Kidney Injury Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Acute Kidney Injury Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Quark Pharmaceuticals Company Details
Table 62. Quark Pharmaceuticals Business Overview
Table 63. Quark Pharmaceuticals Acute Kidney Injury Therapeutics Product
Table 64. Quark Pharmaceuticals Revenue in Acute Kidney Injury Therapeutics Business (2016-2021) & (US$ Million)
Table 65. Quark Pharmaceuticals Recent Development
Table 66. Alloksys Company Details
Table 67. Alloksys Business Overview
Table 68. Alloksys Acute Kidney Injury Therapeutics Product
Table 69. Alloksys Revenue in Acute Kidney Injury Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Alloksys Recent Development
Table 71. Angio Biomedica Corporation Company Details
Table 72. Angio Biomedica Corporation Business Overview
Table 73. Angio Biomedica Corporation Acute Kidney Injury Therapeutics Product
Table 74. Angio Biomedica Corporation Revenue in Acute Kidney Injury Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Angio Biomedica Corporation Recent Development
Table 76. Stealth Bio Therapeutics Company Details
Table 77. Stealth Bio Therapeutics Business Overview
Table 78. Stealth Bio Therapeutics Acute Kidney Injury Therapeutics Product
Table 79. Stealth Bio Therapeutics Revenue in Acute Kidney Injury Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Stealth Bio Therapeutics Recent Development
Table 81. Silver Creek Pharmaceuticals Company Details
Table 82. Silver Creek Pharmaceuticals Business Overview
Table 83. Silver Creek Pharmaceuticals Acute Kidney Injury Therapeutics Product
Table 84. Silver Creek Pharmaceuticals Revenue in Acute Kidney Injury Therapeutics Business (2016-2021) & (US$ Million)
Table 85. Silver Creek Pharmaceuticals Recent Development
Table 86. AM Pharma Holding Company Details
Table 87. AM Pharma Holding Business Overview
Table 88. AM Pharma Holding Acute Kidney Injury Therapeutics Product
Table 89. AM Pharma Holding Revenue in Acute Kidney Injury Therapeutics Business (2016-2021) & (US$ Million)
Table 90. AM Pharma Holding Recent Development
Table 91. Ischemix Company Details
Table 92. Ischemix Business Overview
Table 93. Ischemix Acute Kidney Injury Therapeutics Product
Table 94. Ischemix Revenue in Acute Kidney Injury Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Ischemix Recent Development
Table 96. Biomerieux Company Details
Table 97. Biomerieux Business Overview
Table 98. Biomerieux Revenue in Acute Kidney Injury Therapeutics Business (2016-2021) & (US$ Million)
Table 99. Biomerieux Recent Development
Table 100. A1M Pharma Company Details
Table 101. A1M Pharma Business Overview
Table 102. A1M Pharma Acute Kidney Injury Therapeutics Product
Table 103. A1M Pharma Revenue in Acute Kidney Injury Therapeutics Business (2016-2021) & (US$ Million)
Table 104. A1M Pharma Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Kidney Injury Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Non-drug Features
Figure 3. Drugs Features
Figure 4. Global Acute Kidney Injury Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinic Case Studies
Figure 7. Other Case Studies
Figure 8. Acute Kidney Injury Therapeutics Report Years Considered
Figure 9. Global Acute Kidney Injury Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Acute Kidney Injury Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Acute Kidney Injury Therapeutics Market Share by Regions: 2020 VS 2027
Figure 12. Global Acute Kidney Injury Therapeutics Market Share by Regions (2022-2027)
Figure 13. Global Acute Kidney Injury Therapeutics Market Share by Players in 2020
Figure 14. Global Top Acute Kidney Injury Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Kidney Injury Therapeutics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Acute Kidney Injury Therapeutics Revenue in 2020
Figure 16. Global Acute Kidney Injury Therapeutics Revenue Market Share by Type (2016-2021)
Figure 17. Global Acute Kidney Injury Therapeutics Revenue Market Share by Type (2022-2027)
Figure 18. North America Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Acute Kidney Injury Therapeutics Market Share by Type (2016-2027)
Figure 20. North America Acute Kidney Injury Therapeutics Market Share by Application (2016-2027)
Figure 21. North America Acute Kidney Injury Therapeutics Market Share by Country (2016-2027)
Figure 22. United States Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Acute Kidney Injury Therapeutics Market Share by Type (2016-2027)
Figure 26. Europe Acute Kidney Injury Therapeutics Market Share by Application (2016-2027)
Figure 27. Europe Acute Kidney Injury Therapeutics Market Share by Country (2016-2027)
Figure 28. Germany Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Acute Kidney Injury Therapeutics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Acute Kidney Injury Therapeutics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Acute Kidney Injury Therapeutics Market Share by Region (2016-2027)
Figure 38. China Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Acute Kidney Injury Therapeutics Market Share by Type (2016-2027)
Figure 46. Latin America Acute Kidney Injury Therapeutics Market Share by Application (2016-2027)
Figure 47. Latin America Acute Kidney Injury Therapeutics Market Share by Country (2016-2027)
Figure 48. Mexico Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Acute Kidney Injury Therapeutics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Acute Kidney Injury Therapeutics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Acute Kidney Injury Therapeutics Market Share by Country (2016-2027)
Figure 54. Turkey Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Acute Kidney Injury Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Quark Pharmaceuticals Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2016-2021)
Figure 58. Alloksys Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2016-2021)
Figure 59. Angio Biomedica Corporation Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2016-2021)
Figure 60. Stealth Bio Therapeutics Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2016-2021)
Figure 61. Silver Creek Pharmaceuticals Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2016-2021)
Figure 62. AM Pharma Holding Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2016-2021)
Figure 63. Ischemix Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2016-2021)
Figure 64. Biomerieux Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2016-2021)
Figure 65. A1M Pharma Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
世界の急性腎障害治療市場規模・現状・予測（2021年-2027年） Acute kidney injury (AKI) is where your kidneys suddenly stop working properly. It can range from minor loss of kidney function to complete kidney failure. Market Analysis and Insights: Global Acute Kidney Injury Treatment Market The global Acute Kidney Injury Treatment market size is projected to r…- 世界のICU（集中治療室）における急性腎治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global ICU-acquired Acute Kidney Treatment Market The global ICU-acquired Acute Kidney Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and hig…
- 世界の急性興奮＆攻撃性治療市場規模・現状・予測（2021年-2027年） With acute agitation and aggression being a common symptom among patients suffering from various types of mental illnesses, the healthcare industry is expending efforts towards developing effective panaceas. Market Analysis and Insights: Global Acute Agitation and Aggression Therapeutics Market The …
- 世界の白質傷害治療市場規模・現状・予測（2021年-2027年） White matter is a part of brain that works as a cable that connect entire thing together and transmit signals. Market Analysis and Insights: Global White Matter Injury Treatment Market The global White Matter Injury Treatment market size is projected to reach US$ XX million by 2027, from US$ XX mill…
- 世界の重症急性呼吸器症候群（SARS）治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Market The global Severe Acute Respiratory Syndrome(SARS) Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-sta…